Newsroom

  • Pulmonary Medicine

    Leader in Care

    Throughout the Washington, DC, region, the nation and the world, Children’s National Health System is recognized for our expertise and innovation in pediatric care and as an advocate for all children.

    Read more
  • Research

    Leader in research

    Our desire to provide the most compassionate clinical care is complemented by our dedication to improving treatments and the quality of life for patients and their families.

    Read more
  • Leukemia Lymphoma Program

    Expert on your side

    Several specially trained people dedicated to children’s medicine care for your child, working together to give your family the best possible treatment.

    Meet a nurse

Latest News

Evidence review supports pediatric use of PDE 5 inhibitors for pulmonary hypertension

A systematic review of the comparative effectiveness and safety of phosphodiesterase type 5 (PDE-5) inhibitors in pediatric patients with pulmonary hypertension published Feb. 24, 2017 in Pediatrics demonstrates that scientific evidence supports the use of this class of medications in infants, neonates and children with pulmonary hypertension.

Children’s National Announces the Creation of First-of-its-Kind Rare Disease Institute

Children's National Health System, the nation’s largest provider of care for children with rare genetic disorders, announced it has formed the Children’s National Rare Disease Institute (CNRDI), a first-of-its-kind center focused exclusively on advancing the care and treatment of children and adults with rare genetic diseases.